Nearly all cases of hepatocellular carcinoma (HCC), the most common form of liver cancer, are caused by either chronic liver inflammation (hepatitis) and/or metabolic alterations, which mechanistically are linked to hepatocyte cell death, compensatory regeneration, and excessive mammalian target of rapamycin (mTOR) activation [1–3]. The gene discussed is MTOR; the disease is liver cancer.